HAMC hydrogel, modified with a RGD peptide and PDGF-A, promoted early survival and integration of grafted cells. Teratoma formation was attenuated when cells were transplanted in the hydrogel, where most cells differentiated to a glial phenotype. The gene discussed is PDGFA; the disease is teratoma.